GL1X · GenesisL1 explorer

UniProt Q9Y468

Lethal(3)malignant brain tumor-like protein 1 (Q9Y468)

Lethal(3)malignant brain tumor-like protein 1 (UniProt Q9Y468): 40 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound, 9 pockets. Binding sites, druggability and experiment against prediction (TM-score)…

UniProt
Q9Y468
Protein
Lethal(3)malignant brain tumor-like protein 1
Experimental structures
40
Predicted models
1
Ligands
2
Pockets
9 · 2 records with a druggable one

Structures

41 records of Q9Y468 in the MolNFT archive: 40 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1OYXCrystal structure of 3-mbt repeats of lethal (3) malignant brain tumor (seleno-met) at 1.85 ångströmx-ray diffractionA, B, C——
1OYXCrystal structure of 3-mbt repeats of lethal (3) malignant brain tumor (seleno-met) at 1.85 ångströmx-ray diffractionA, B, C——
1OZ2Crystal structure of 3-mbt repeats of lethal (3) malignant brain tumor (native-II) at 1.55 ångströmx-ray diffractionA——
1OZ2Crystal structure of 3-mbt repeats of lethal (3) malignant brain tumor (native-II) at 1.55 ångströmx-ray diffractionA——
1OZ3Crystal Structure of 3-MBT repeats of lethal (3) malignant Brain Tumor (Native-I) at 1.85 angstromx-ray diffractionA, B, C——
1OZ3Crystal structure of 3-mbt repeats of lethal (3) malignant brain tumor (native-I) at 1.85 ångströmx-ray diffractionA, B, C——
2PQWCrystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), trigonal formx-ray diffractionA——
2PQWCrystal structure of L3MBTL1 in complex with H4K20ME2 (residues 17- 25), trigonal formx-ray diffractionA——
2RHICrystal structure of the 3-MBT domain from human L3MBTL1 in complex with H1.5K27me2 at 1.66 angstromx-ray diffractionA——
2RHICrystal structure of the 3-mbt domain from human L3MBTL1 in complex with H1.5K27ME2 at 1.66 ångströmx-ray diffractionA——
2RHUCrystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine and in chimera…x-ray diffractionA——
2RHUCrystal structure of the 3-mbt repeats from human L3MBTL1 bound to dimethyl-lysine and in chimera…x-ray diffractionA——
2RHXCrystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysinex-ray diffractionA——
2RHXCrystal structure of the 3-mbt repeats from human L3MBTL1 bound to dimethyl-lysinex-ray diffractionA——
2RHYCrystal structure of the 3-MBT repeats from human L3MBTL1 bound to monomethyl-lysinex-ray diffractionA——
2RHYCrystal structure of the 3-mbt repeats from human L3MBTL1 bound to monomethyl-lysinex-ray diffractionA——
2RHZCrystal structure of the 3-MBT repeats from human L3MBTL1 with D355N point mutationx-ray diffractionA——
2RHZCrystal structure of the 3-mbt repeats from human L3MBTL1 with D355N point mutationx-ray diffractionA——
2RI2Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355A point mutationx-ray diffractionA——
2RI2Crystal structure of the 3-mbt repeats from human L3MBTL1 with D355A point mutationx-ray diffractionA——
2RI3Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358Q point mutationx-ray diffractionA——
2RI3Crystal structure of the 3-mbt repeats from human L3MBTL1 with N358Q point mutationx-ray diffractionA——
2RI5Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358A point mutationx-ray diffractionA——
2RI5Crystal structure of the 3-mbt repeats from human L3MBTL1 with N358A point mutationx-ray diffractionA——
2RJCCrystal structure of L3MBTL1 protein in complex with MESx-ray diffractionA, B, C——
2RJCCrystal structure of L3MBTL1 protein in complex with mesx-ray diffractionA, B, C——
2RJDCrystal structure of L3MBTL1 proteinx-ray diffractionA——
2RJDCrystal structure of L3MBTL1 proteinx-ray diffractionA——
2RJECrystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), orthorhombic form IIx-ray diffractionA, B, C——
2RJECrystal structure of L3MBTL1 in complex with H4K20ME2 (residues 17- 25), orthorhombic form IIx-ray diffractionA, B, C——
2RJFCrystal structure of L3MBTL1 in complex with H4K20Me2 (residues 12-30), orthorhombic form Ix-ray diffractionA, C, E——
2RJFCrystal structure of L3MBTL1 in complex with H4K20ME2 (residues 12- 30), orthorhombic form Ix-ray diffractionA, C, E——
3OQ5Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with p53K382me1x-ray diffractionA, B, C——
3OQ5Crystal structure of the 3-mbt domain from human L3MBTL1 in complex with P53K382ME1x-ray diffractionA, B, C——
3P8HCrystal structure of L3MBTL1 (MBT repeat) in complex with a nicotinamide antagonistx-ray diffractionA, B, C——
3P8HCrystal structure of L3MBTL1 (mbt repeat) in complex with a nicotinamide antagonistx-ray diffractionA, B, C——
3UWNThe 3-MBT repeat domain of L3MBTL1 in complex with a methyl-lysine mimicx-ray diffractionA——
3UWNThe 3-mbt repeat domain of L3MBTL1 in complex with a methyl-lysine mimicx-ray diffractionA——
6BYBCrystal structure of L3MBTL1 MBT Domain with MBK14970x-ray diffractionAEC7, UNX2 (best 0.70)
6BYBCrystal structure of L3MBTL1 mbt domain with MBK14970x-ray diffractionAEC7, UNX—
Q9Y468AlphaFold monomer V2.0 prediction for LETHAL(3)MALIGNANT brain tumor- like protein 1 (Q9Y468)predictedA—7 (best 0.74)

Ligands

  • EC7 · (S)-N-(cyclopropylmethyl)-N~2~-methyl-N-[2-methyl-2-(1-methylpiperidin-4-yl)propyl]alaninamide · in 2 records
  • UNX · Unknown atom or ion · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.